A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases-Reference-Cited by-同舟云学术

A novel morphology-based risk stratification model for stage I uterine leiomyosarcoma: an analysis of 203 cases

Published:2022-06 Issue:6 Volume:35 Page:794-807
ISSN:0893-3952
Container-title:Modern Pathology
language:en
Short-container-title:Modern Pathology

Author:

Chapel David B.^ORCID,Sharma Aarti,Lastra Ricardo R.,Maccio Livia,Bragantini Emma,Zannoni Gian Franco^ORCID,George Suzanne,Quade Bradley J.,Parra-Herran Carlos^ORCID,Nucci Marisa R.

Funder

Ovarian Cancer Research Fund Alliance

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Link

https://www.nature.com/articles/s41379-022-01011-z.pdf

Reference47 articles.

1. Analysis of clinicopathologic prognostic factors for 157 uterine sarcomas and evaluation of a grading score validated for soft tissue sarcoma;Pautier;Cancer,2000

2. Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999;Brooks;Gynecol. Oncol.,2004

3. Uterine sarcomas in Norway. A histopathological and prognostic survey of a total population from 1970 to 2000 including 419 patients;Abeler;Histopathology,2009

4. Incidence of soft tissue sarcoma and beyond: a population-based prospective study in 3 European regions;Mastrangelo;Cancer,2012

5. Uterine sarcoma: analysis of 13,089 cases based on surveillance, epidemiology, and end results database;Hosh;Int. J. Gynecol. Cancer,2016

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Uterine Smooth Muscle Tumors: An Overview;Advances in Anatomic Pathology;2024-04-19

2. Macroscopic examination of gynaecological specimens: a critial and often underemphasised aspect of pathological reporting;Journal of Clinical Pathology;2024-02-19

3. Primary Ovarian Leiomyosarcoma Is a Very Rare Entity: A Narrative Review of the Literature;Cancers;2023-05-28

4. Morphological parameters of uterine body leiomyosarcoma associated with survival rates;Pelvic Surgery and Oncology;2023-04-20

5. Loss of dystrophin is common in uterine leiomyosarcoma: a potential biomarker for clinical application;Human Pathology;2023-04